School districts face enormous pressure to make smart decisions when they’re buying academic resources. If they make the wrong moves, it’s not just taxpayers who suffer. Students do, too. School ...

It’s not just Tesla under fire for how its electronic door handles respond after a crash, fire, or even a total power loss. In the early hours of Monday morning, a Xiaomi SU7 in China crashed and ...

This is read by an automated voice. Please report any issues or inconsistencies here. At its core, a civil suit is about money. Nobody pleads guilty. Nobody goes to prison. Somebody either pays ...

A new study from MIT's NANDA initiative has found that 95% of generative AI pilots fail to deliver measurable ROI for companies – a failure rate rooted not in flawed models but in poor integration and ...

President Trump could be headed to the Middle East this weekend, but first he's headed to Walter Reed Medical Center. That's the Bethesda, Md., hospital where Trump was taken when he had Covid near ...

The top Senate Republican indicated Wednesday he may hold votes on standalone bills to fund parts of the government, amid an impasse on how to end the shutdown. Senate Majority Leader John Thune told ...

In the wake of the deaths of two teenage girls in Cranford earlier this week, and with the understanding that at least one of the girls was being stalked by the individual who has been charged with ...

In a 3–3 tie, Boston had runners at first and second thanks to wildness from Yankees starter Carlos Rodon (who from the first pitch of the inning could not command the ball and kept looking at his ...

After a Senate vote late Tuesday night along mostly party lines failed to pass a “clean” Continuing Resolution (CR) that would fund the government through November 21st, the federal government shut ...

Two bills to fund the government have failed in the Senate, leaving Congress careening toward a shutdown with hours to go before a midnight deadline. Democratic and Republican leaders remain at an ...

Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price ...

A phase 2b trial of Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) drug candidate has missed its primary endpoint. But, with other analyses generating signs of efficacy, the biotech made ...